Los Angeles Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,504
| Closed | -$167K | – | 1382 |
|
|
2025
Q1 | $167K | Buy |
20,504
+30
| +0.1% | +$245 | ﹤0.01% | 1047 |
|
|
2024
Q4 | $193K | Hold |
20,474
| – | – | ﹤0.01% | 1060 |
|
|
2024
Q3 | $219K | Buy |
20,474
+6,484
| +46% | +$69.2K | ﹤0.01% | 1103 |
|
|
2024
Q2 | $139K | Sell |
13,990
-104,370
| -88% | -$1.04M | ﹤0.01% | 1142 |
|
|
2024
Q1 | $1.39M | Buy |
118,360
+105,384
| +812% | +$1.24M | ﹤0.01% | 585 |
|
|
2023
Q4 | $184K | Hold |
12,976
| – | – | ﹤0.01% | 1102 |
|
|
2023
Q3 | $158K | Buy |
+12,976
| New | +$158K | ﹤0.01% | 1079 |
|
|
2021
Q3 | – | Sell |
-42,422
| Closed | -$409K | – | 1515 |
|
|
2021
Q2 | $409K | Sell |
42,422
-76,582
| -64% | -$738K | ﹤0.01% | 1262 |
|
|
2021
Q1 | $1.18M | Sell |
119,004
-28,936
| -20% | -$286K | 0.01% | 819 |
|
|
2020
Q4 | $3.42M | Sell |
147,940
-8,010
| -5% | -$185K | 0.01% | 496 |
|
|
2020
Q3 | $2.2M | Sell |
155,950
-69,715
| -31% | -$984K | 0.01% | 542 |
|
|
2020
Q2 | $3.4M | Buy |
225,665
+1,022
| +0.5% | +$15.4K | 0.02% | 483 |
|
|
2020
Q1 | $2.08M | Buy |
224,643
+105,339
| +88% | +$973K | 0.01% | 525 |
|
|
2019
Q4 | $1.16M | Buy |
119,304
+97,980
| +459% | +$954K | 0.01% | 795 |
|
|
2019
Q3 | $171K | Sell |
21,324
-79,706
| -79% | -$639K | ﹤0.01% | 1220 |
|
|
2019
Q2 | $1.26M | Buy |
101,030
+5,915
| +6% | +$73.8K | 0.01% | 771 |
|
|
2019
Q1 | $1.29M | Buy |
95,115
+65,750
| +224% | +$895K | 0.01% | 771 |
|
|
2018
Q4 | $281K | Sell |
29,365
-16,550
| -36% | -$158K | ﹤0.01% | 1125 |
|
|
2018
Q3 | $555K | Sell |
45,915
-1,830
| -4% | -$22.1K | ﹤0.01% | 1073 |
|
|
2018
Q2 | $746K | Buy |
47,745
+6,420
| +16% | +$100K | ﹤0.01% | 1019 |
|
|
2018
Q1 | $622K | Buy |
+41,325
| New | +$622K | ﹤0.01% | 967 |
|